Viewing Study NCT00056459


Ignite Creation Date: 2025-12-24 @ 3:06 PM
Ignite Modification Date: 2026-01-14 @ 5:11 AM
Study NCT ID: NCT00056459
Status: COMPLETED
Last Update Posted: 2020-02-10
First Post: 2003-03-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
Sponsor: Novartis
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CPTK787 0135/306241
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: External Affairs
Old Organization: Novartis

Collaborators

Collaborators

Name Class View
None INDUSTRY View